Drug Shortage Report for TEVA-AZATHIOPRINE
Report ID | 123720 |
Drug Identification Number | 02236819 |
Brand name | TEVA-AZATHIOPRINE |
Common or Proper name | AZATHIOPRINE 50MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AZATHIOPRINE |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | L04AX |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-09-03 |
Estimated end date | 2020-11-30 |
Actual end date | 2020-12-02 |
Shortage status | Resolved |
Updated date | 2020-12-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2020-12-03 | French | Compare |
v6 | 2020-12-03 | English | Compare |
v5 | 2020-10-30 | French | Compare |
v4 | 2020-10-30 | English | Compare |
v3 | 2020-09-04 | English | Compare |
v2 | 2020-09-03 | French | Compare |
v1 | 2020-09-03 | English | Compare |
Showing 1 to 7 of 7